Successful marketing of medicinal cannabis and cannabis-derived products: part II
Barbara Siebertz, Senior Manager, Regulatory Affairs and Special Projects, and Ute Hegener, Director, Regulatory Affairs at PharmaLex, discuss the current legal and marketing situation in Europe